Characterization of tumor necrosis factor-deficient mice
about
Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulinAnti-cytokine therapy in chronic destructive arthritisMembrane TNF confers protection to acute mycobacterial infection.How Follicular Dendritic Cells Shape the B-Cell AntigenomeTNF biology, pathogenic mechanisms and emerging therapeutic strategiesIL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicansManagement of inflammatory bowel disease in pregnancyHistorical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journeyBoth functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malariaIL-1 Coordinates the Neutrophil Response to C. albicans in the Oral MucosaSurfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class ATNF-alpha in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit?Embryonic mouse submandibular salivary gland morphogenesis and the TNF/TNF-R1 signal transduction pathwayWhole-body deletion of LPS-induced TNF-α factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritisIdentification, structural characterization, and tissue distribution of Tsg-5: a new TNF-stimulated genePoints of control in inflammationConstitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressureTNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice.Microdissection of the cytokine milieu of pulmonary granulomas from tuberculous guinea pigs.Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis.Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice.Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE).Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages.Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitorC/EBPalpha is critical for the neonatal acute-phase response to inflammationThe rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destructionDifferential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection.How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli.Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression"Inflammatory" cytokines: neuromodulators in normal brain?Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium aviumPyrin-only protein 2 limits inflammation but improves protection against bacteria.Different tumor necrosis factor α antagonists have different effects on host susceptibility to disseminated and oropharyngeal candidiasis in mice.Divergence of protection induced by bacterial products and sepsis-induced immune suppression.TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection.Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection.Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.Dose-dependent activation of lymphocytes in endotoxin-induced airway inflammation.
P2860
Q24646364-FCB65F0D-F0E5-41E8-A8E2-1F23D3AC23F9Q24805245-6C78590A-DACA-4425-8AE1-CF4B74AA107CQ25257300-EEF5B6CF-1025-42DD-82CD-7835AD5AEC33Q26742173-C915E3C7-2DEA-4619-80E9-648E25CD15D1Q26776492-419DA2D7-F213-4A6F-82F4-0590CEE6ACADQ26799351-E2132281-4B88-47A6-8A94-3CD7CE5BE14DQ26865914-11D3DD80-DD7F-435E-98E2-5B159C9ECA6AQ26991848-989A208A-5369-442E-8213-C938A69AE2E4Q27300897-44550485-AB84-47CD-8CB5-29B5DC0D1F29Q27312015-2AB5F5C9-84FE-48CD-915B-725CFE0E58E9Q28117813-FDEDEC54-F6B4-4C38-87AC-6FAB662B88AFQ28389009-39CED2A0-8E3E-4B63-AB63-9C68895F10E6Q28506544-09139C9B-5E7D-46B0-BE31-B6F0A6203BDCQ28511199-A7F9225F-79C2-4662-8A45-1B4724183A5EQ28586121-46E52B69-05E8-4FA5-9274-1B2FB014CEE7Q29620319-F86F7D8E-1255-4043-A516-A8F0540FBA70Q30358256-15B6A45A-B914-465E-8022-E28E029D0A71Q30490532-99EBE00D-81C8-4749-9931-2B26909D493FQ33268910-57AF48FE-350C-4A01-951F-0C8D41305108Q33552079-12A28C3A-CC50-419E-AA08-B2449DCA5BCEQ33597224-2C53DE45-0188-4368-91DE-E835ECC34092Q33692956-1AE304E2-65D4-45D5-A77F-6B4AD485465AQ33716100-42AD70FC-30FB-43EE-B3C9-AFAF56428723Q33754239-A784902E-5402-45DA-9450-EF162A9B0D6DQ33781735-50CE2F59-93D0-4C99-A588-3DC87CC7CFF4Q33782321-ED2C7A35-331E-4E51-82D2-07F14FCA7AC8Q33782333-4B4CED02-5392-4525-98AF-6F70674B1401Q33787988-4ECBF822-6AB4-4E76-BE5D-62EBA94BB1EEQ33815922-9DF334FB-6310-4485-A67E-DB6A8BD10EB8Q33821187-FB36DFF3-6535-4692-AB70-C8B65EEC6FEDQ33824014-40C4364B-0FD4-4BB4-B03B-4119AAF798DFQ33877173-06BE6923-D1A3-4D1C-B17E-836C476DDB7CQ33908383-5272C7EA-14B7-41BE-A415-D79D0E77E44EQ33927362-F232DDA0-1B38-475B-9288-6624A1FFEF76Q33946614-7B09116A-7F84-441F-9417-FB520AE8028EQ33947075-53FE180D-F210-40F6-8DC9-0991FFE6F94EQ34003476-157DCCEB-F551-40A9-BDC9-1381B60E3BCEQ34004035-1B22D9AE-F574-45EA-AF30-20C16E3BBFB2Q34005000-73494EDF-331A-42A6-AFEA-DC3110B80187Q34005287-063C4434-35C9-4980-941E-6A1A8CAEA5A7
P2860
Characterization of tumor necrosis factor-deficient mice
description
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1997
@ast
im Juli 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/07/22)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/07/22)
@nl
наукова стаття, опублікована в липні 1997
@uk
name
Characterization of tumor necrosis factor-deficient mice
@ast
Characterization of tumor necrosis factor-deficient mice
@en
Characterization of tumor necrosis factor-deficient mice
@nl
type
label
Characterization of tumor necrosis factor-deficient mice
@ast
Characterization of tumor necrosis factor-deficient mice
@en
Characterization of tumor necrosis factor-deficient mice
@nl
prefLabel
Characterization of tumor necrosis factor-deficient mice
@ast
Characterization of tumor necrosis factor-deficient mice
@en
Characterization of tumor necrosis factor-deficient mice
@nl
P2093
P2860
P3181
P356
P1476
Characterization of tumor necrosis factor-deficient mice
@en
P2093
A. Jungbluth
B. Williamson
E. Richards
M. Inglese
M. W. Marino
P2860
P304
P3181
P356
10.1073/PNAS.94.15.8093
P407
P577
1997-07-22T00:00:00Z